Which came first, the cannabis or the depression?
Prev Med Rep. 2024 Jan 13;38:102613. doi: 10.1016/j.pmedr.2024.102613. eCollection 2024 Feb. NO ABSTRACT PMID:38304868 | PMC:PMC10831284 | DOI:10.1016/j.pmedr.2024.102613...
Impact of long-term dietary high fat and eicosapentaenoic acid on behavior and hypothalamic-pituitary-adrenal axis activity in amyloidogenic APPswe/PSEN1dE9 mice
Neuroendocrinology. 2024 Feb 1. doi: 10.1159/000536586. Online ahead of print. ABSTRACT INTRODUCTION: Alzheimer’s disease (AD) alters neurocognitive and emotional function and causes dysregulation of multiple...
Examining Factors Associated with Cannabis Use Among Sexual and Gender Minority and Cisgender Heterosexual Emerging Adults in California
LGBT Health. 2024 Feb 1. doi: 10.1089/lgbt.2023.0050. Online ahead of print. ABSTRACT Purpose: We explored correlates of cannabis risk and examined differences between sexual and...
Non-immunosuppressive treatment for IgA nephropathy
Cochrane Database Syst Rev. 2024 Feb 1;2:CD003962. doi: 10.1002/14651858.CD003962.pub3. ABSTRACT BACKGROUND: IgA nephropathy (IgAN) is the most common primary glomerular disease, with approximately 20% to...
Effects of extended dietary supplementation with Santalum album essential oil on hemato-biochemical changes, innate immune response, antioxidant status, and expression of related gene in Nile tilapia (Oreochromis niloticus)
Fish Physiol Biochem. 2024 Feb 1. doi: 10.1007/s10695-024-01309-6. Online ahead of print. ABSTRACT The effects of long-term dietary supplementation with sandalwood (Santalum album L.) essential...
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Int Clin Psychopharmacol. 2024 Feb 2. doi: 10.1097/YIC.0000000000000536. Online ahead of print. ABSTRACT This study aims to analyze changes in health-related quality of life (HRQoL)...
Unravelling the landscape of Cannabis craving pharmacological treatments: a PRISMA-guided review of evidence
Int Rev Psychiatry. 2023 Aug-Sep;35(5-6):434-449. doi: 10.1080/09540261.2023.2231540. Epub 2023 Jul 21. ABSTRACT Currently, few treatments are available for craving in general, and none of them...
Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence
Int Rev Psychiatry. 2023 Aug-Sep;35(5-6):377-396. doi: 10.1080/09540261.2023.2229430. Epub 2023 Jun 28. ABSTRACT The opioid crisis remains a major public health concern, causing significant morbidity and...
Resolvin D1 as a novel target in the management of hypertension
J Hypertens. 2024 Mar 1;42(3):393-395. doi: 10.1097/HJH.0000000000003641. Epub 2024 Feb 1. NO ABSTRACT PMID:38289998 | DOI:10.1097/HJH.0000000000003641...
Effect of torrefaction on fuel properties of biopellets
Heliyon. 2024 Jan 10;10(2):e23989. doi: 10.1016/j.heliyon.2024.e23989. eCollection 2024 Jan 30. ABSTRACT The study aimed to determine the effects of torrefaction on the fuel properties of...
New Developments in Understanding and Treating Opiate and Cannabis Use Disorders
Am J Psychiatry. 2024 Feb 1;181(2):83-86. doi: 10.1176/appi.ajp.20231018. NO ABSTRACT PMID:38298078 | DOI:10.1176/appi.ajp.20231018...
Fenofibrate Recognition and Gq Protein Coupling Mechanisms of the Human Cannabinoid Receptor CB1
Adv Sci (Weinh). 2024 Jan 31:e2306311. doi: 10.1002/advs.202306311. Online ahead of print. ABSTRACT The G-protein-coupled human cannabinoid receptor 1 (CB1) is a promising therapeutic target...
Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings
Drug Alcohol Depend. 2024 Jan 24;256:111108. doi: 10.1016/j.drugalcdep.2024.111108. Online ahead of print. ABSTRACT INTRODUCTION: Substance use disorders (SUDs) are underdiagnosed in healthcare settings. The Substance...
Reply to: Cognitive Safety of Cannabis Products in Parkinson’s Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds
Mov Disord. 2024 Jan;39(1):222-223. doi: 10.1002/mds.29667. NO ABSTRACT PMID:38294047 | DOI:10.1002/mds.29667...
The biological effects and thermal degradation of NPB-22, a synthetic cannabinoid
Forensic Toxicol. 2024 Jan 31. doi: 10.1007/s11419-023-00679-5. Online ahead of print. ABSTRACT PURPOSE: NPB-22 (quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate), Adamantyl-THPINACA (N-(1-adamantantyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide), and CUMYL-4CN-B7AICA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide), synthetic cannabinoids were...